[Clinical trial of a new synthetic product: o-ethoxybenzylhydrazone of diethanolamine pyruvate associated with vitamins B 1, B 6 and B 12 and dichloroethanoate of diisopropylammonium in the treatment of rheumatic and neuritic pain syndromes].
D000605:Amino Alcohols / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D009443:Neuritis / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use; D011773:Pyruvates / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013831:Thiamine / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D000605:Amino Alcohols; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011773:Pyruvates; D011736:Pyridoxine; D014805:Vitamin B 12; D013831:Thiamine
Sperimentazione clinica di un nuovo prodotto di sintesi: l'o-etossilbenzoil-idrazone del piruvato di dietanolamina associato alle vitamine B 1, B 6, e B 12 ed al dicloroetanoato di diisopropilammonio nel trattamento delle sindromi dolorose reumatiche e nevritiche.